Hansa Biopharma AB (publ) (24H.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 09:09AM CEST. Market open.
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 134.34M |
| Enterprise Value | 169.13M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.91 |
| Price/Book (mrq) | 7.06 |
| Enterprise Value/Revenue | 1.02 |
| Enterprise Value/EBITDA | -0.24 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.26 |
| 52-Week Change 3 | -47.30% |
| S&P500 52-Week Change 3 | 22.38% |
| 52 Week High 3 | 4.9740 |
| 52 Week Low 3 | 1.7140 |
| 50-Day Moving Average 3 | 2.5518 |
| 200-Day Moving Average 3 | 2.7502 |
Share Statistics
| Avg Vol (3 month) 3 | 75 |
| Avg Vol (10 day) 3 | 291 |
| Shares Outstanding 5 | 52.67M |
| Implied Shares Outstanding 6 | 1.42M |
| Float 8 | 32.68M |
| % Held by Insiders 1 | 13.66% |
| % Held by Institutions 1 | 43.08% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in SEK.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -284.72% |
Management Effectiveness
| Return on Assets (ttm) | -41.07% |
| Return on Equity (ttm) | -4,176.67% |
Income Statement
| Revenue (ttm) | 165.88M |
| Revenue Per Share (ttm) | 3.15 |
| Quarterly Revenue Growth (yoy) | 131.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | -762.61M |
| Net Income Avi to Common (ttm) | -844.88M |
| Diluted EPS (ttm) | -1.4700 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 541.47M |
| Total Cash Per Share (mrq) | 10.28 |
| Total Debt (mrq) | 947.12M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.55 |
| Book Value Per Share (mrq) | 1.50 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -737.84M |
| Levered Free Cash Flow (ttm) | -485.58M |
© 2024 Yahoo. All rights reserved.